IRIDEX introduces new XP Module for IQ 532 ENT laser system

NewsGuard 100/100 Score

IRIDEX Corporation (Nasdaq: IRIX) announced the introduction of its new XP Module - a high power factory installed option for the IRIDEX IQ 532 green laser system. The IQ 532 XP is a multifunctional device that can be utilized by both ear, nose and throat (ENT) surgeons and ophthalmologists - expanding overall utilization and making a laser investment more attractive.

The optional XP module doubles the power of the standard IRIDEX IQ 532, facilitating the rapid and efficient treatment of tissue while limiting unwanted thermal effects and provides ENT surgeons with a portable KTP 532 nm laser system that is optimized for their clinical needs.

"We developed the XP module in response to the growing demand from ENT surgeons for higher power output, particularly for use when treating laryngeal pathologies," commented Theodore A. Boutacoff, President & CEO. "When used with our family of ENT probes, physicians are now able to expand their treatment capabilities and achieve clinically effective results in less time. The IQ 532 with the XP Module and the IRIDEX family of ENT probes are optimized for the treatment of soft tissue/vascular lesions of the airway and larynx, including polyps and adhesions."

The addition of the XP Module and FlexFiber delivery devices to our existing ENT product line provides additional sales opportunities and demonstrates IRIDEX's dedication to providing physicians with innovative tools to enhance surgical procedures while improving patient and clinical outcomes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HPV infections increase prostate cancer risk by 2.3 times, study finds